We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
Today, the U.S. Food and Drug Administration approved StrataGraft for the treatment of adult patients with thermal burns containing intact dermal elements (remaining deep skin layers) for which
NorthShore University HealthSystem (NorthShore) has joined physIQ’s NIH-funded DeCODe study to develop an AI-based COVID-19 digital biomarker. NorthShore will serve as an enrollment center and key partner in
Quidel has obtained an amended Emergency Use Authorization (EUA) from the US Food and Drug Administration (FDA) for its Sofia Q, expanding its line of Fluorescent Immunoassay Analysers
Activ Surgical has launched ActivInsights software suite, its augmented reality (AR)-based bundle that offers real-time tissue assessment as visual overlays. The company said that its new ActivInsights software
Avacta Group plc (AIM: AVCT), the developer of diagnostics and innovative cancer therapies based on its proprietary Affimer® and pre|CISION™ platforms, is pleased to announce that it has
Eitan Medical, a global leader in advanced infusion therapy and drug delivery solutions across the care continuum, announced today that MPP Infusion Centers® (Multispeciality Physician Partners), a Joint
Bausch + Lomb, the eye health business of Bausch Health, has partnered with Lochan to develop the new generation of its eyeTELLIGENCE clinical decision support software. The company
Mindray (SZSE: 300760), a global leading developer and provider of medical devices and solutions, has introduced the Nuewa I9, its latest cart-based ultrasound system and tailored solution for
OraSure Technologies has secured the US Food and Drug Administration (FDA) Emergency Use Authorisation (EUA) for three of its InteliSwab brand rapid antigen tests to detect active Covid-19
Royal Philips (NYSE: PHG, AEX: PHIA), and Elekta (EKTA-B.ST) today signed agreements to deepen their existing strategic partnership to advance comprehensive and personalized cancer care through precision oncology